Regulatory and ethical requirements in medical device studies DENMARK

Similar documents
Regulatory and ethical requirements in medical device studies. Finland

Regulatory and ethical requirements in medical devices studies. France

Regulatory and ethical requirements in medical devices studies. Turkey

Regulatory and ethical requirements in medical devices studies. Portugal

Regulatory and ethical requirements in medical devices studies. Italy

State Institute for Control of Drugs-/ Státní ústav pro control léčiv (SÚKL) Regulatory and ethics bodies involved in approval process

Regulatory and ethics bodies involved in approval process. CA - Submission for authorisation mandatory for

Regulatory and ethics bodies involved in approval process for trials. National Ethics Committee; Agency for Data Protection;

Health Registration and Training Center (HRTC/ENKK) , Mail: 1380 P.O. Box 1188 (Street: Zrinyi u. 3.

Competent federal higher authority ("Bundesoberbehörde- BOB")

APPLICATION FORM. Application for a Recognised Research Ethics Committee (REC) Opinion on a Clinical Trial on a Medicinal Product for Human Use.

Regulatory and ethics bodies involved in approval process. CA - Registration requirements for clinical trials

Investigator Site File Index (Medical Devices)

ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL

Implementation of the EU-law. Tom Van Paepegem Quality co-ordinator D.R.U.G.

PROCEDURE OF FILING A REQUEST TO THE ETHICS COMMITEE OF THE UNIVERSITY CLINICAL CENTRE OF THE REPUBLIC OF SRPSKA

Central Committee for Research Involving Human Subjects/ Centrale Commissie Mensgebonden Onderzoek (CCMO) NB! if CCMO acts as CA:

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria

Impact of Clinical EU Directive on the implementation of Early development studies in Europe

A SHORT GUIDE TO THE PROCEDURE FOR A CLINICAL TRIAL APPLICATION IN THE KINGDOM OF BAHRAIN

Belgian Center for Pharamcovigilance for medicines for Human use (BCPH): faggafmps.be

RSC/CT Det. no. 1/2013

The Norwegian Medicines Agency NoMA (Statens legemiddelverk) Section for Preclinical Assessment and Clinical Trials

STANDARD OPERATING PROCEDURE FOR RESEARCH. 17. Study Close Down

ICH GCP Revision and EU Clinical Trial Regulation

Danish Act on Clinical Trials of Medicinal Products 1

NIS Considerations - Bulgaria

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Ireland

GUIDELINES ON MEDICAL DEVICES

GUIDELINES ON MEDICAL DEVICES

STANDARD OPERATING PROCEDURE. STH Researcher. Investigator Site File

Clinical trials from CRA s point of view

Regulatory Newsletter January - March 2014

Highlights of the proposed Clinical Trials Regulation in Europe

Clinical Trials application process, legislation & guidelines

ANNEX. CHAPTER I General principles

Impact of the transposition of the European Clinical Trials Directive. CEMO, Paris 17 November 2004

IRB-GCP and Timelines. Andrew Majewski, MSc. 1 st DOLF Meeting Washington University School of Medicine St Louis, Missouri-USA October th, 2010

Standard Operating Procedure

NOTICE. Subject: Stakeholders suggestions/comments on Clinical Trials conductance in India

Investigator Site File Index (CTIMP)

VERSION: 21 st June Date of Publication: 15 th March C/ CAMPEZO, 1 EDIFICIO MADRID Tel.: Fax:

Index of Standard Operating Procedures for all research Sponsored by the UHL

Audit and Regulatory Inspection Nopanan Yaibuathes Clinical Research and Compliance Manager Roche Thailand Ltd.

PROPOSED DOCUMENT. Global Harmonization Task Force. Title: Reportable Events During Pre-Market Clinical Investigations

Guide for Manufacturers and Sponsors on Clinical Investigations Carried Out in Ireland

MEDICINES CONTROL COUNCIL

Once notified of the end of trial, a Research Manager, on behalf of the Sponsor, will contact the CI to arrange a close down monitoring visit.

Index of Standard Operating Procedures for all research Sponsored by the UHL

Meeting the Clinical Evaluation Requirements for CE Marking: Challenges for Innovative Start-ups Sarah Sorrel, MedPass International SAS

The European Medicines Agency Inspections ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA:

Study Files and Filing

INSPECTION OF INDEPENDENT ETHICS COMMITTEES (IEC) The Italian Experience

Bundesamt für Sicherheit im Gesundheitswesen BASG/ Federal Office for Safety in Health Care

Annual report 2011 Clinical trials of medicines in humans

OVERVIEW OF DIRECTIVE 2001/20. Paul Derbyshire. Background & History. Aims of Directive 2001/20

EU Clinical Trial Regulation A view from the Industry

Development Safety Update Report Guidance

Good Clinical Practice, GCP. Clinical Trials 101 GCIG CCRN QA

COMMENTS FROM EUROPABIO GENERAL COMMENTS

Research Study Close-down and Archiving Procedures

Guidance for participating parties version 2.0, DISCLAIMER

Clinical Research: A Multifaceted Discipline

The Victorian Streamlined Review Process and the National Mutual Acceptance (NMA) Streamlined Review Process for Clinical Trials

Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE

Office for Human Subject Protection. University of Rochester

WCG ACADEMY COURSE OVERVIEW

Clinical Trials Environment EU Legislation: Ausblick auf die neue Gesetzgebung für klinische Prüfungen

Standard Operating Procedure

Conducted Under an IND to Support a

GUIDELINES FOR CONDUCTING CLINICAL TRIALS.

Folder Name Documents included Explanation

Guidance for applicants for ethics committee opinion on the conduct of a clinical trial of pharmaceuticals

The future clinical trial authorisation process: the new evaluation process

Human Research Protection Program Policy

Pharmacovigilance and safety reporting for sponsored ATIMPs/CTIMPs

REVISION OF THE CLINICAL TRIALS DIRECTIVE 2001/20/EC UK RESPONSE TO CONCEPT PAPER

Comment by the Federal Institute for Drugs and Medical Devices in coordination with the Paul Ehrlich Institute and the Federal Ministry of Health

Review of EU Clinical Trial Directive. 15 May 2012 Mike Beckers Sidley Austin LLP, Brussels

STANDARD OPERATING PROCEDURE SOP 310

Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products

Course Title ID Duration Basic Premium. Biological Evaluation of Medical Devices: A Risk-Based Approach N mins

Trial Master File. SOP No. SOP 7

Louise Brook Clinical Trials Quality Monitor. Date

Regulatory Affairs: Study Report of New Drug Registration Process in European Union

3.1. Overall Principal Investigator (PI), who holds the IND and is the Sponsor.

ESSENTIAL DOCUMENTS DURING THE CLINICAL CONDUCT OF THE TRIAL

How did it evolve? o Public disasters, serious fraud and abuse of human rights. o Trials of War criminals-nuremberg code 1949

Practical Conduct of Clinical Trials

3 RESPONSIBILITIES AND AUTHORITIES

OFFICE FOR RESEACH PROCEDURE. Sponsor Responsibilities in Investigator Initiated Studies

Federal agency for medicines and health products

RAC (EU) Examination Study Checklist

3.1. Overall Principal Investigator (PI), who holds the IND and is the Sponsor.

Track III: International Clinical Trials: Global Compliance Norms and EU Focus

Annex IV to guidance for the conduct of good clinical practice inspections sponsor and CRO

Good Clinical Practice (GCP): how does a laboratory that supports a clinical trial ensure compliance with these Regulations

STUDY DOCUMENTS. DOCUMENT NO.: CR007 v4.0. Marise Buçukoğlu ISSUE DATE: 07 MAR 2017 EFFECTIVE DATE: 21 MAR INTRODUCTION

Submitting a CTA application to the MHRA

Inspection of the conduct of clinical evaluations on medical devices in the premises of healthcare providers

Transcription:

Regulatory and ethical in medical device studies DENMARK

SECTIONS A.Type of research

SECTIONS A.Type of research

We have differentiated 8 types of research: Medical device alone with CE mark use within label Medical device alone with CE mark use outside label Medical device alone without CE mark Medical device combined with medicinal product with CE mark use within label Medical device combined with medicinal product with CE mark use outside label Medical device combined with medicinal product without CE mark Observational studies with medical device Registries

SECTIONS A.Type of research

H. Data Ptotection Definitions in Danish law The following are sources for the definition for clinical research in medical device studies in Denmark: Danish Health Danish Medicines Agency Danish Data Protection Agency

Conventions/guideline/laws to apply ICH Guideline of EMA European Directive 2011/20/EC These apply for all medical device studies other than observational studies and registry studies.

Acts to apply For device with CE mark used within label: Data Protection Act Ethics Law In addition, for medical device studies alone with CE mark use outside label, for medical device alone without CE mark and for medical devices with or without CE mark combined with medicinal product Medical Device Act Drug Act For medical devices combined with medicinal product

SECTIONS A.Type of research

For all the type of medical device studies listed, it is not necessary to cover insurance for - Patients or healthy volunteers - Investigators - Sponsors - Manufacturers No mandatory compensation sum per participant or per trial is required.

SECTIONS A.Type of research

It is mandatory to have a sponsor in all the interventional studies listed below: Medical device alone with CE mark use within label Medical device alone with CE mark use outside label Medical device alone without CE mark Medical device combined with medicinal product with CE mark use within label Medical device combined with medicinal product with CE mark use outside label Medical device combined with medicinal product without CE mark

SECTIONS A.Type of research

There are no specific /regulations for GCP training of the investigators in Denmark for any of the study types.

SECTIONS A.Type of research

Danish Competent :! As from 8 October 2015, Danish Health and Medicines (DHMA) has been split into three agencies. Until January 2016, the DHMA website will display information and guidance from the Danish Health, the Danish Medicines Agency and parts of the Danish Patient Safety In January 2016, they will launch three new websites.

Danish Competent : Danish Health and Medicines http://www.sundhedsstyrelsen.dk/en/ Danish Health Islands Brygge 67 2300 Copenhagen S Denmark sst@sst.dk Tel. +45 72 22 74 00 Danish Medicines Agency Ael Heides Gade 1 2300 Copenhagen S Denmark dkma@dkma.dk Tel. +45 44 88 95 95 Sundhedsstyrelsen.dk/en/

Medical device alone with CE mark use within label Medical device alone with CE mark use outside label Medical device alone without CE mark Medical device combined with medicinal product with CE mark use within label Medical device combined with medicinal product with CE mark use outside label Medical device combined with medicinal product without CE mark Approval Yes No

Initial submission The sponsor is responsible for the submission. The submission to the Danish Competent is national: you only have to submit one dossier to the national competent authority The submission has to be : -online via Eudralink/DKMAnet or http://sundhedsstyrelsen.dk/en/medicines/regul ation/clinical-trials/applications -by CD-ROM or English documents are accepted Submission fee is 2,600 Euro to 3400 Euro

Initial submission There is a standard application form - see link below: http://sundhedsstyrelsen.da.da/medicin/medicins k-udstyr/klinisk-afproevning/ansoegning-omklinisk-afproevning 60 days maimum to obtain approval No need to have some kind of representative or a legal entity in Denmark to submit an application to the Competent

F. Competant Initial submission Main documents required for submission: Submission letter Clinical Trial application form Clinical Investigation Plan/Protocol Clinical Investigation Plan/ Protocol signed Clinical Investigation Plan/Protocol summary Investigator s brochure or CE certificate Instruction for use/technical manual Financial disclosure

- Vigilance It is mandatory to declare AEs, ADE, SADE and SAEs to the Danish Competent. The sponsor is responsible for declaring Adverse Events to the Competent Authorities in the specific countries Danish Competent authority has a standard form for SAE reporting. See link below: Sundhedsstyrelsen.dk/en/medicines/medicaldevices/incident-reporting-system

- Vigilance H. Data Ptotection Events mandatory to declare to the Competent : Medical device alone with CE mark use within label Medical device alone with CE mark use outside label AE ADE SADE SAE Medical device alone without CE mark Medical device combined with medicinal product with CE mark use within label Medical device combined with medicinal product with CE mark use outside label Medical device combined with medicinal product without CE mark Observational studies with medical device AE: Adverse Event (Non device related) ADE: Adverse Device Effect (Device or procedure related) SADE: Serious adverse Device Effect (Device or procedure related) SAE: Serious Adverse Event (Non device related)

- Vigilance SAE definition = standard ICH-GCP definition, including near incident. SAE declaration by the sponsor - all serious adverse events, including nearincidents- immediately and no later than 7 days -a serious adverse event which indicates an imminent risk of death, serious injury, or serious illness and which requires prompt remedial action for other patients/subjects, users or other persons must be reported no later than 2 days AEs are reported in a final report

- Vigilance The sponsor needs to provide an annual safety report to the Danish Competent for studies involving: Medical device alone with CE mark use outside label Medical device alone without CE mark Medical device combined with medicinal product with CE mark use within label, Medical device combined with medicinal product with CE mark use outside label Medical device combined with medicinal product without CE mark

- Vigilance The sponsor is responsible for the declaration to the Competent Special form for the declaration of AE:

Substantial amendment There is a specific procedure for submitting a substantial amendment to the Danish Competent

SECTIONS A.Type of research

11 Local committees in 5 regional committees. Contact should be made via the regional committees. The National Committee on Health Research Ethics, Holbergsgade 6, 1057 København K, Tlf: +45 72 26 93 70, http://www.cvk.sum.dk/, E- mail: DKetik@DKetik.dk 1. Regional ethics committee for the Capital Region: Kongens Vænge 2, 3400 Hillerød, Tlf. +45 38 66 63 95, www.regionh.dk/vek, E-mail: vek@regionh.dk 2. Regional ethics committee for the Region Zealand: Alléen 15, 4180 Sorø, Tlf. +45 24 52 59 52, www.regionsjaelland.dk/videnskabsetiskkomite, E-mail: RH-komite@regionsjaelland.dk 3. Regional ethics committee for the South of Denmark: Regionshuset, Damhaven 12, 7100 Vejle, Tlf. +45 20 59 89 30, +45 29 20 22 51, +45 29 20 22 52 og +45 29 20 12 03, www.regionsyddanmark.dk/komite, E-mail: komite@rsyd.dk 4. Regional ethics committee for the Central Region of Denmark: Regionssekretariatet, Juridisk Kontor, Skottenborg 26, 8800 Viborg, Tlf. +45 78 41 01 83, +45 79 41 01 85, +45 78 41 01 81, +45 78 41 01 82, www.komite.rm.dk, E-mail: komite@rm.dk 5. Regional ethics committee for the Region North of Denmark: Regionssekretariatet, Niels Bohrs Vej 30, 9220 Aalborg Ø, Tlf. +45 97 64 84 40, www.vek.rn.dk, E-mail: vek@rn.dk

Medical device alone with CE mark use within label Medical device alone with CE mark use outside label Medical device alone without CE mark Medical device combined with medicinal product with CE mark use within label Medical device combined with medicinal product with CE mark use outside label Medical device combined with medicinal product without CE mark Positive opinion required Yes No

Initial submission The sponsor is responsible for submission. The submission to the Ethics Committee is local: you only have to submit one dossier to one of the regional Ethics Committee The submission has to be: - Online via email, using a digital signature Or - Via the online portal DKMAnet English documents are accepted Submission fee is 650 to 950 Euro

Initial submission H. Data Ptotection In general, 60 days to obtain approval No implicit approval Deadlines for submissions When both Competent approval and Ethics Committee positive opinion are required, it is possible to request the 2 in parallel. No need to have some kind of representative or a legal entity in Denmark to to submit an application to the Competent or Ethics Committee.

Initial submission H. Data Ptotection Main documents required for submission: Submission letter Clinical Trial application form Clinical Investigation Plan/Protocol Clinical Investigation Plan/Protocol summary Inform Consent Form and subject Information leaflet General Practitioner information letter Copy of advertisement materials for research participant Financial disclosure

G. Ethics committee Initial submission Standard application form Standard application form available on the DNVK website: www.fnvk.dk/englis.h/notification%20of%20%c linical%20trial.asp:

- Vigilance Sponsor is responsible for SAE declaration to Ethics Committee : Timeline: 7 days in device trial not involving a medicinal product. The sponsor also has to declare events to the Ethics Committee in the specific countries Annual safety report must be provided to the Ethics Committee

- Vigilance Events mandatory to declare to the competent authority in Denmark: Medical device alone with CE mark use within label Medical device alone with CE mark use outside label AE ADE SADE SAE Medical device alone without CE mark Medical device combined with medicinal product with CE mark use within label Medical device combined with medicinal product with CE mark use outside label Medical device combined with medicinal product without CE mark Observational studies with medical device AE: Adverse Event (Non device related) ADE: Adverse Device Effect (Device or procedure related) SADE: Serious adverse Device Effect (Device or procedure related) SAE: Serious Adverse Event (Non device related)

- Vigilance The sponsor is responsible for the declaration to the Ethics Committee A Special form is used for the declaration of AE to the Ethics Committee.

Substantial amendment There is a specific procedure for submitting a substantial amendment to the Ethics Committee

SECTIONS A.Type of research

Danish Data Protection Agency: www.datatilsynet.dk/english/

Medical device alone with CE mark use within label Medical device alone with CE mark use outside label Medical device alone without CE mark Medical device combined with medicinal product with CE mark use within label Medical device combined with medicinal product with CE mark use outside label Medical device combined with medicinal product without CE mark Notification required Yes No

Submission in English is accepted by the Danish data protection agency No submission fee

SECTIONS A.Type of research

H. Data Ptotection In Denmark there are specific /regulations for the following specific populations: - Children Ethics Law + written consent from parts or legal guardians - Pregnant and lactating women Ethics law www.ema.europa.eu/docs/en_gb/document_library/scientif ic_guideline/2009/09/wc500002877.pdf - Incapacitated adults written consent from legal guardian or nearest relatives - Emergency situations: written consent post incident.

No specific in Denmark re compensation fees for subjects participating in clinical research No national healthy volunteers registry in Denmark

SECTIONS A.Type of research

Specific to publish both positive, negative and inconclusive results of clinical studies in journals or in registries such as ClinicalTrials.gov or EurdraCT. No specific to provide devices without CE mark, or used outside intended use for free. Specific regarding devices emitting radiation. Approval needs to be granted by the National Institute of Radiation. Specific re ICF but not detailed here.

No specific /regulations regarding archiving of documentation Specific regarding blood/tissue samples: Blood banks and centres must be authorised by the Danish Patient Safety. No specific for data management of clinical investigations. Specific strategies for monitoring of medical device studies are : labelling and instructions

It is not mandatory to register clinical studies in a registry. There is no official national register for clinical studies in Denmark.